CRC Add to watchlist $64.93 +1.23 (+1.93%) Last updated: Apr 16, 2026 00:36
52-Week Range
$64.93
$33.85 $64.93 $71.98

Fundamentals Overview

California Resources Corporation is near the high of its 52-week range with moderate valuation, trading relatively flat today.

Valuation moderate

P/E 15.6 P/B 1.54 P/S 1.66

Intrinsic value (DCF)

+124.8% upside vs price

Profitability

Net margin 10.4%

Risk (Beta)

1.03 — in line vol

Earnings & growth

EPS $4.15 Rev -0.8% Profit -81.3% vs prior qtr

BullzEye Analysis

Our composite tilts Buy on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.

Composite Signal

Sell
Buy
Buy — 77% confidence Risk: Moderate Volatility — Beta 1.03. Diversify and only invest what you can afford to lose.

Supporting (Buy):

DCF +124.8% upside vs price · Analyst grade: A- · Sentiment improving (2 upgrades) · 3M vs S&P 500: +42.3% · 3M vs Energy sector: +22.7%

Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.

Key Stats

Market Cap
$5.76B
P/E (TTM)
15.63
EPS (TTM)
$4.15
Dividend Yield
2.44%
52-Week Range
$33.85 - $71.98
Volume vs Avg
N/A
Beta
1.03

About

California Resources Corporation operates as an independent oil and natural gas company. The company explores for, produces, gathers, processes, and markets crude oil, natural gas, and natural gas liquids for marketers, California refineries, and other purchasers that have access to transportation and storage facilities. As of December 31, 2021, it had interests in approximately 1.9 million net mineral acres with proved reserves totaled an estimated 480 million barrels of oil equivalent. The com...
Sector: Energy
Headquarters: US
Employees: 1,550
IPO Date: Oct 2020
Website: www.crc.com
Beta: 1.03 (More volatile than market)

Ratings & Grades at a Glance

Overall rating: A-. Recent institutional grades: majority upgrades. Current institutional positions: Buy: 11, Neutral: 4, Outperform: 4, Overweight: 11.

Financial story & AI narrative

Open this tab to load the financial story.

Valuation & Ratios

Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.

DCF vs price: DCF estimate is $145.98; current price is $64.93. That’s a +124.8% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.

Metric Value
Valuation
P/E (TTM) 15.63
DCF value (model) $145.98 (124.8% upside)
PEG (TTM) N/A
P/B (TTM) 1.54
P/S (TTM) 1.66
P/FCF (TTM) 10.61
Liquidity & enterprise
Current Ratio (TTM) 0.89
Quick Ratio (TTM) 0.79
Cash Ratio (TTM) 0.13
Profitability
ROE (TTM) N/A
ROA (TTM) N/A
Revenue growth (YoY) N/A
Net margin (TTM) 10.44%
Gross margin (TTM) 37.4%
Operating margin (TTM) 20.83%
Debt to equity (TTM) N/A

Latest News

News loads when you open this tab.

Price Target, Ratings & Grades

Analyst price targets, consensus, rating snapshot, and institutional grades for CRC.

Analyst Sentiment at a Glance

A- Sentiment Improving
Buy 11Neutral 4Outperform 4Overweight 11
2 upgrades, 0 downgrades
Price Target Consensus
Current $64.93
Median $67.50
Consensus $68.33
Low consensus $56.00
High consensus $84.00

Stock Grades (Institutions)

Institution Action Previous Grade New Grade Date
UBS maintain Buy Buy 2026-04-13
Citigroup maintain Neutral Neutral 2026-03-30
Citigroup maintain Neutral Neutral 2026-03-18
Wells Fargo maintain Overweight Overweight 2026-03-17
Barclays maintain Overweight Overweight 2026-03-16
UBS maintain Buy Buy 2026-03-05
Wells Fargo maintain Overweight Overweight 2026-03-04
Barclays maintain Overweight Overweight 2026-03-03
UBS maintain Buy Buy 2026-01-26
Barclays maintain Overweight Overweight 2026-01-21
UBS maintain Buy Buy 2025-12-12
Mizuho maintain Outperform Outperform 2025-12-12
Wells Fargo maintain Overweight Overweight 2025-12-09
UBS maintain Buy Buy 2025-11-10
Barclays maintain Overweight Overweight 2025-11-06
JP Morgan maintain Overweight Overweight 2025-10-10
B of A Securities maintain Buy Buy 2025-09-22
Barclays maintain Overweight Overweight 2025-09-16
UBS maintain Buy Buy 2025-09-16
Mizuho maintain Outperform Outperform 2025-09-15
B of A Securities maintain Buy Buy 2025-09-03
UBS maintain Buy Buy 2025-08-20
Mizuho maintain Outperform Outperform 2025-08-08
UBS maintain Buy Buy 2025-08-08
Citigroup maintain Neutral Neutral 2025-07-17
JP Morgan upgrade Neutral Overweight 2025-07-15
UBS maintain Buy Buy 2025-07-14
Mizuho maintain Outperform Outperform 2025-07-14
Barclays upgrade Equal Weight Overweight 2025-05-30
Citigroup maintain Neutral Neutral 2025-05-19